Tharimmune (THAR) Announces Positive Topline “Itching” Data.

Tharimmune Announces Positive Topline Data with TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Chronic Liver Disease Patients Phase...

Psychedelic Happy Hour – Miami

Meet and Greet for Wonderland Miami Psychedelic Conference. November 10th. Guests will enjoy...

Psycheceutial Biosciences (BWVI) Listed on WeFunder!

Psycheceutical’s Psychedelic Experience, a Safer More Viable Choice in Getting Treated. Imagine the benefits of psychedelics, without hallucinating!

Cybin (CYBN) Announces Unprecedented Positive Phase 2 Data After Single Dose.

Conference call to discuss CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET

Psychedelics CURED My Alcoholism

RELATED: Matthew Perry Reveals he Spent About $9M Trying to get Sober. Psychedelics CURED...

ClearMind’s (CMND) MEAI and Reducing Alcohol Use.

Amazing New Technologies Keep Popping up. We love when this happens during Sector Bear Markets, which Psychedelics have...

ABVC BioPharma (ABVC) up 160% on News

And the Day-Traders Say, I'll Drink to That! LIVE QUOTE

Adial (ADIL). Don’t Give up Drinking. Just Drink Less!

Hmm, Now Here's a Novel Idea and Every Heavy Drinkers Dream! Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies...

Citius Pharma (CTXR) to Merge Subsidiary, with Publicly Traded SPAC. Shares up 17%.

We Would Define This as Huge News.. Citius Pharma would receive 67.5...

Ardelyx (ARDX) $3.40, Receives FDA Approval.

BooYah, Ardelyx shoots and we score (again) last week..but wait, there's more! It trades down post-approval as short-term...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...